This study found that patients treated with semaglutide and tirzepatide had generally similar characteristics, such as age, gender, and starting weight before treatment
8.6 Renal Impairment No dose adjustment of OZEMPIC is recommended for patients with renal impairment
Proven Efficacy: Achieves up to 17% weight loss in patients with full treatment adherence, matching the established clinical outcomes of weekly injections
I started researching weight loss medications and considered my options
These stories do not represent typical, guaranteed, or independently verified results
In addition to GLP-1 meds and meal plans, FHs program includes virtual doctor consultations and other support to build habits that last well beyond GLP-1 use. Cost of meds and food is in addition to a $99 monthly subscription